This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Buy Amazon Here

03/05/14 - 05:28 PM EST

The company still hasn't recovered since its quarterly report. That is a gift and it is time to come into the stock

READ FULL POST

Honeywell: Why It's At All-Time Highs

03/05/14 - 05:24 PM EST

Honeywell has mastered a five year plan that works

READ FULL POST

Nat Gas Export: The Next Horizon

03/04/14 - 03:51 PM EST

The latest disruptions in Ukraine and Russia are merely another reason to push for natural gas export

READ FULL POST

Why Abercrombie is up this morning

02/26/14 - 09:37 AM EST

Forgiveness in retail is the story of the last five days. And with Abercrombie in particular, expectations came low enough to allow the stock to surge

READ FULL POST

This Week: The Retail Tell

02/24/14 - 08:48 PM EST

The effect of weather lingers, but we will get a sense of company standing from guidance

READ FULL POST

Biotech Continues to Lead Market: Innovation and M&A

02/18/14 - 10:35 PM EST

The big news of today was Actavis' announcement o buy Forest Labs for $25 billion. And this is much more than just another win for Carl Icahn, the second largest holder of Forest Labs, which has gotten a lot of focus in media outlets.

READ FULL POST

Online Travel Agencies: Secular Winners

02/13/14 - 10:42 AM EST

Want to try to game these as a trade? Don't try - they are long-term winners

READ FULL POST

Conundrum: Can Amazon Handle Increased Prime Pricing?

02/12/14 - 12:06 PM EST

UBS published a troubling report today on Amazon's ability, or lack thereof, to raise prices on their Amazon Prime service. The survey found that while 94% of Amazon Prime customers surveyed indicated they would likely renew at the $79 current annual fee, those percentages dropped precipitously when price increases of $20 and $40 were introduced (to 58% and 24%, respectively).

READ FULL POST

Building Products: The Pink Panther as a Leader?

02/12/14 - 11:19 AM EST

While the homebuilders align more strongly with rate changes, the building products group is a way to play cyclical improvement in construction and home pricesimproving--not to mention non-residential construction where we are seeing a turn.

READ FULL POST

Social Media: Yelping Momentum for Market

02/10/14 - 11:34 AM EST

Over the weekend, media outlets reported that Yahoo was partnering with Yelp on Local Search. Here's why it matters.

READ FULL POST

Nicole Urken is Research Director of Mad Money and Jim Cramer's researcher at TheStreet. Nicole analyzes stocks and develops a strategic macro outlook, which she incorporates into segment ideas for CNBC's "Mad Money." Nicole also supports Jim's other endeavors including "Squawk on the Street," RealMoney.com, and his latest best-selling book "Get Rich Carefully."

Previously, she worked as an investment banking analyst for the Industrials Group in Goldman Sachs' New York office. Born and raised in Princeton, New Jersey, Nicole graduated with honors from Harvard College, where she served as executive editor of The Harvard Crimson.

Markets

DOW 17,131.97 +100.83 0.59%
S&P 500 1,998.98 +14.85 0.75%
NASDAQ 4,552.7590 +33.8570 0.75%

Nicole's Tweets

Brokerage Partners

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs